510(k) K221206
K221206 is an FDA 510(k) premarket notification submitted by Serpex Medical, Inc. for the device "Compass Steerable Needle". The FDA issued a decision of Substantially Equivalent on Aug 25, 2022. The device falls under product code KTI (Bronchoscope Accessory), a Class II device regulated under 21 CFR 874.4680. Serpex Medical, Inc. has 4 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 25, 2022
- Date Received
- Apr 26, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Bronchoscope Accessory
- Device Class
- Class II
- Regulation Number
- 874.4680
- Review Panel
- EN
- Submission Type
- 510(k)
If the device is reusable, validated reprocessing instructions and reprocessing validation data for this device type must be included in a 510(k) submission (82 FR 26807, available at https://www.gpo.gov/fdsys/pkg/FR-2017-06-09/pdf/2017-12007.pdf).
Need the full FDA record for Serpex Medical, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.